Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/122851
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Mezquita-Raya, Pedro |
dc.contributor.author | Darbà, Josep |
dc.contributor.author | Ascanio, Meritxell |
dc.contributor.author | Ramírez de Arellano, Antonio |
dc.date | 2018-06-08T07:50:15Z |
dc.date | 2018-11-30T06:10:18Z |
dc.date | 2017-11 |
dc.date | 2018-06-08T07:50:15Z |
dc.identifier.citation | 1473-7167 |
dc.identifier.citation | 676690 |
dc.identifier.uri | http://hdl.handle.net/2445/122851 |
dc.format | 9 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Informa Healthcare |
dc.relation | Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2017.1345628 |
dc.relation | Expert Review of Pharmacoeconomics & Outcomes Research, 2017, vol. 17, num. 6, p. 587-595 |
dc.relation | https://doi.org/10.1080/14737167.2017.1345628 |
dc.rights | (c) Informa Healthcare, 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Anàlisi cost-benefici |
dc.subject | Salut pública |
dc.subject | Diabetis |
dc.subject | Insulina |
dc.subject | Cost effectiveness |
dc.subject | Public health |
dc.subject | Diabetes |
dc.subject | Insulin |
dc.title | Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |